News Focus
News Focus
Followers 3
Posts 942
Boards Moderated 0
Alias Born 03/11/2009

Re: rmtd post# 1574

Thursday, 04/02/2009 10:54:45 AM

Thursday, April 02, 2009 10:54:45 AM

Post# of 7234
Novartis has an option on pixantrone and, if exercised, would pay CTIC a $7.5M fee and up to $104M in registration and sales related milestones.

Stay tuned…

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up